Medication-Assisted Treatment Is Becoming a Core Jail and Prison Health Strategy

Medication-assisted treatment, often called MAT or more precisely medication for opioid use disorder (MOUD), is increasingly treated as a standard part of correctional health care rather than an optional add-on. In Oregon, that shift matters because jails and prisons regularly serve people with opioid use disorder, and incarceration can interrupt treatment at the exact moment when continuity is most important. Oregon Health Authority describes MAT as a medically monitored approach that combines medication with counseling and support services, and the state continues to frame it as a key tool for reducing overdose risk and supporting recovery. ([oregon.gov](https://www.oregon.gov/oha/HSD/AMH/Pages/MAT.aspx))

For people in custody, the issue is not only whether treatment is available inside the facility. It is also whether treatment continues after release. That transition period is high-risk, especially for people who have lost opioid tolerance during incarceration. Oregon's current policy direction reflects that reality: the state is investing in jail-based treatment and transition planning, while correctional health services in the Department of Corrections provide ongoing medical, behavioral, and pharmacy care to adults in custody. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

Why MAT in Jails and Prisons Matters

Opioid use disorder is a chronic medical condition, and stopping medication abruptly can increase withdrawal, relapse, and overdose risk. In correctional settings, those risks can be amplified by stress, unstable housing after release, and limited access to community care. Oregon's public health materials emphasize that treatment access remains a major need statewide, and that medication-based treatment is one of the most effective evidence-based responses to opioid use disorder. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Pages/index.aspx))

In practical terms, MAT in custody can include medications such as methadone or buprenorphine, along with counseling and care coordination. The goal is not simply to manage symptoms inside the jail or prison. It is to stabilize the person, reduce illicit opioid use, and create a safer path back to the community. Oregon's health agencies describe MAT as a therapeutic intervention that can improve quality of life and support recovery when paired with psychosocial services. ([oregon.gov](https://www.oregon.gov/oha/HSD/AMH/Pages/MAT.aspx))

What Oregon Is Doing in Jails

Oregon has taken a notable step through the Jail-based Medications for Opioid Use Disorder Grant Program, commonly referred to as JMOUD. The Oregon Criminal Justice Commission says the program was created under House Bill 4002 in 2024 to provide opioid use disorder treatment and transition planning services to people in local correctional facilities and tribal correctional facilities. That makes Oregon one of the states actively building a statewide jail-treatment infrastructure rather than leaving implementation entirely to local discretion. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

The program is not just symbolic. Oregon's published 2025-2027 funding table shows allocations to many county jails and facilities across the state, including large and small jurisdictions. That suggests a broad effort to expand access beyond a few pilot sites. The state legislature also expanded the program's scope in 2025 by broadening the definition of local correctional facility so more county facilities can participate in opioid use disorder treatment and transition planning. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Documents/JMOUD_Formula_Funding_Table_2025-2027.pdf))

Oregon's grant structure also reflects a systems-level approach. The Criminal Justice Commission administers the program, while state rules and legislative materials indicate that grantees are expected to address operational barriers such as secure medication storage and collaboration with treatment providers. In other words, Oregon is not only funding medication; it is funding the infrastructure needed to deliver it safely in custody. ([oregonlegislature.gov](https://www.oregonlegislature.gov/bills_laws/ors/ors169.html))

What About Prisons?

Prisons and jails are not identical, and Oregon's policy tools differ by setting. The Oregon Department of Corrections says its Health Services provide legally mandated medical, dental, behavioral health, and pharmacy services to adults in custody. That means prison health care already includes a framework for ongoing treatment, though the exact scope of MAT can depend on clinical need, security considerations, and facility operations. ([oregon.gov](https://www.oregon.gov/doc/inmate-services/pages/health-and-wellness.aspx))

Oregon has also moved to expand medication-assisted treatment within the Department of Corrections. A recent DOC rulemaking notice states that the department anticipates expanding medication-assisted treatment for opioid use disorder, signaling continued policy movement inside state prisons. Because correctional health policy can change quickly, the safest reading is that Oregon is actively working to broaden access, but the details may vary by facility and by implementation timeline. ([oregon.gov](https://www.oregon.gov/doc/rules-and-policies/Documents/291-105-Expansion-of-the-Medication-Assisted-Treatment.pdf))

How Oregon Connects In-Custody Care to Reentry

One of the strongest arguments for MAT in jails and prisons is reentry planning. Oregon's JMOUD program explicitly includes transition planning, which is important because release from custody is a vulnerable period for overdose and treatment drop-off. The state's opioid settlement materials also show funding for training and technical assistance to jails so they can improve access to MOUD and coordinate with opioid treatment programs. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

That coordination matters because many people leaving custody need a bridge to community care, not a restart from zero. Oregon's health agencies maintain resources for opioid treatment programs and MAT access, and the state's public health guidance emphasizes reducing barriers to treatment and making care more accessible and affordable. In a correctional context, that can mean discharge planning, medication continuity, referrals, and rapid linkage to community providers. ([oregon.gov](https://www.oregon.gov/oha/HSD/AMH/Pages/MAT.aspx))

Challenges Oregon Still Faces

Even with strong policy momentum, implementation is not simple. Jails vary widely in size, staffing, medical capacity, and access to prescribers. Rural counties may face different barriers than urban facilities. Secure storage, medication diversion concerns, transportation, telemedicine access, and staffing shortages can all affect how well MAT works in practice. Oregon's grant rules and funding materials suggest the state recognizes these barriers, but funding alone does not eliminate them. ([oregonlegislature.gov](https://www.oregonlegislature.gov/bills_laws/ors/ors169.html))

There is also the broader challenge of continuity after release. A person can receive excellent care in custody and still struggle if they leave without insurance, transportation, housing, or a scheduled appointment. Oregon's approach appears to acknowledge this by pairing treatment with transition planning, but the real-world success of the model depends on local coordination and follow-through. That is an inference based on the state's emphasis on transition planning and community linkage. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

Why This Matters for Public Safety and Public Health

MAT in correctional settings is often discussed as a health issue, but it also has public safety implications. When treatment reduces withdrawal, relapse, and overdose risk, it can lower emergency responses, improve stability after release, and support better engagement with supervision and services. Oregon's policy choices suggest the state sees correctional treatment as part of a larger overdose-response strategy, not a separate silo. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Pages/index.aspx))

For Oregon, the current direction is clear: expand access, reduce barriers, and make sure treatment does not stop at the jail door or prison gate. The state's recent grant program, funding allocations, and correctional health rulemaking show a system that is still evolving, but moving toward a more consistent model of care. For people with opioid use disorder, that can make the difference between a temporary interruption and a dangerous break in treatment. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

Bottom Line

As of June 12, 2026, Oregon is actively expanding medication-assisted treatment in jails and working to strengthen treatment access in prisons through correctional health services and rule changes. The state's current approach combines medication, counseling, transition planning, and funding support for local facilities. That is a cautious but meaningful shift toward treating opioid use disorder in custody as a medical condition that requires continuity of care before, during, and after incarceration. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Pages/default.aspx))

• MAT/MOUD in custody can reduce withdrawal and support recovery.
• Oregon's JMOUD grant program is now a major jail-focused policy tool.
• Transition planning is central because release is a high-risk period.
• Prison health services in Oregon are also moving toward broader treatment access.

Other Relevant Articles for Oregon

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate